UMIN-CTR History
Name： UMIN ID：
| Unique ID issued by UMIN | UMIN000019616 |
|---|---|
| Receipt number | R000022429 |
| Scientific Title | Phase II study of neoadjuvant nab-paclitaxel and trastuzumab for ER negative and HER2 positive breast cancer |
| Date of disclosure of the study information | 2015/11/04 |
| Last modified on | 2019/05/07 11:36:36 |
| No. | Disposal | Last modified on | Item of update | |
|---|---|---|---|---|
| 1 | Insert | 2015/11/03 11:05:09 | ||
| 2 | Update | 2015/11/03 11:33:35 | Key secondary outcomes |
|
| 3 | Update | 2015/11/19 17:50:27 | Primary outcomes Primary outcomes |
|
| 4 | Update | 2019/05/07 11:33:25 | 1st name of lead principal investigator Last name of lead principal investigator 1st name of lead principal investigator Last name of lead principal investigator Zip code Last name of contact person Last name of contact person Organization Organization Division name Division name Zip code Address Address TEL Organization Organization Division name Division name Address Address TEL Name of primary person or sponsor Institute Institute Organization Organization Organization Organization Address Address Tel Secondary IDs Study ID_1 Org. issuing International ID_1 Org. issuing International ID_1 |
|
| 5 | Update | 2019/05/07 11:36:00 | Recruitment status Date of IRB Last follow-up date |
|
| 6 | Update | 2019/05/07 11:36:36 | Publication of results Number of participants that the trial has enrolled |
